<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3046">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04706325</url>
  </required_header>
  <id_info>
    <org_study_id>kocaeli derh</org_study_id>
    <nct_id>NCT04706325</nct_id>
  </id_info>
  <brief_title>COVID-19 RELATED KIDNEY DAMAGE</brief_title>
  <official_title>INVESTIGATION OF RISK FACTORS RELATED TO COVID-19 RELATED KIDNEY DAMAGE: A PROSPECTIVE OBSERVATIONAL STUDY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli Derince Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli Derince Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we investigate whether the early detection of risk factors in Covid-19&#xD;
      associated acute kidney injury contributes to us in the early initiation of treatment. We&#xD;
      predict that if acute kidney damage is detected early in patients with early risk factors,&#xD;
      permanent kidney damage will be seen less. In addition, we think that covid-19 patients may&#xD;
      have positive contributions to shortening treatment time and reducing treatment costs. In&#xD;
      addition, we are investigating whether it has a positive effect on patients' survival. In&#xD;
      other words, we are investigating the contribution of risk factors to early diagnosis and&#xD;
      treatment, the effect on health expenditures and mortality in patients with COVID-19 with&#xD;
      acute kidney damage.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>KDIGO</measure>
    <time_frame>4 MONTHS</time_frame>
    <description>Kidney Disease: Improving Global Outcomes</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE</arm_group_label>
    <description>COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE</arm_group_label>
    <description>COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.</arm_group_label>
    <description>COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACUTE KIDNEY INJURY</intervention_name>
    <description>KDIGO LEVELS</description>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction) AND CT POSITIVE</arm_group_label>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction) AND CT will be evaluated as NEGATIVE.</arm_group_label>
    <arm_group_label>COVİD19 PCR (Polymerase Chain Reaction)NEGATİVE AND CT POSITIVE</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Over 18 aged&#xD;
&#xD;
          -  patients in ICU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over 18 aged&#xD;
&#xD;
          -  patients in ICU&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known Chronic Renal Failure&#xD;
&#xD;
          -  who have received dialysis treatment before&#xD;
&#xD;
          -  who are under 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>akif şahin</last_name>
    <role>Principal Investigator</role>
    <affiliation>kocaeli derh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mehmet yılmaz</last_name>
    <phone>05052174432</phone>
    <email>drmyilmaz33@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Akif Şahin</name>
      <address>
        <city>Kocaeli</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mehmet yılmaz</last_name>
      <phone>05052174432</phone>
      <email>drmyilmaz33@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.</citation>
    <PMID>32247631</PMID>
  </results_reference>
  <results_reference>
    <citation>Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour Sh, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9:e31. doi: 10.34172/jnp.2020.31</citation>
  </results_reference>
  <results_reference>
    <citation>Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.</citation>
    <PMID>32222812</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli Derince Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Aki̇f Şahi̇n</investigator_full_name>
    <investigator_title>md</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

